| 中文 |
| Home | Application | Peer Group Statistics (Table 1) | Month vs. Cumulative (Table 2) | QC Chart of Individual Lab |
| NS001 |
| CI | CII | |||
| QC Control Lot No. | TPC1502AC | TPC1502AD | ||
| ReagentKit | Astoria-Pacific | |||
| Unit | mg/dL blood | |||
| Duration of the Analyzing | Month (2019/05) | CUM (2018/01/01~2019/05/31) | Month (2019/05) | CUM (2018/01/01~2019/05/31) |
| Runs (N) | 0 | 6 | 0 | 6 |
| Mean | - | 3.0 | - | 12.5 |
| SD | - | 0.21 | - | 0.68 |
| CV (%) | - | 7.0 | - | 5.4 |
| Target Value | 2.9 | 2.9 | 12.5 | 12.5 |
| Total Error (%) | - | 17.4 | - | 10.9 |
| TEa (%) | 10 | 10 | 10 | 10 |
| σ | - | 0.9 | - | 1.9 |
| CI | CII | |||
| QC Control Lot No. | TPC1502AC | TPC1502AD | ||
| ReagentKit | Bio-Rad | |||
| Unit | mg/dL blood | |||
| Duration of the Analyzing | Month (2019/05) | CUM (2018/01/01~2019/05/31) | Month (2019/05) | CUM (2018/01/01~2019/05/31) |
| Runs (N) | 0 | 1 | 0 | 1 |
| Mean | - | 3.5 | - | 12.0 |
| SD | - | - | - | - |
| CV (%) | - | - | - | - |
| Target Value | 2.9 | 2.9 | 12.5 | 12.5 |
| Total Error (%) | - | - | - | - |
| TEa (%) | 10 | 10 | 10 | 10 |
| σ | - | - | - | - |
| CI | CII | |||
| QC Control Lot No. | TPC1502AC | TPC1502AD | ||
| ReagentKit | Cambridge | |||
| Unit | mg/dL blood | |||
| Duration of the Analyzing | Month (2019/05) | CUM (2018/01/01~2019/05/31) | Month (2019/05) | CUM (2018/01/01~2019/05/31) |
| Runs (N) | 0 | 3 | 0 | 3 |
| Mean | - | 3.0 | - | 13.0 |
| SD | - | 0.50 | - | 0.50 |
| CV (%) | - | 16.7 | - | 3.8 |
| Target Value | 2.9 | 2.9 | 12.5 | 12.5 |
| Total Error (%) | - | 36.8 | - | 11.7 |
| TEa (%) | 10 | 10 | 10 | 10 |
| σ | - | 0.4 | - | 1.6 |
| CI | CII | |||
| QC Control Lot No. | TPC1502AC | TPC1502AD | ||
| ReagentKit | Astoria-Pacific | |||
| Unit | umol/L blood | |||
| Duration of the Analyzing | Month (2019/05) | CUM (2018/01/01~2019/05/31) | Month (2019/05) | CUM (2018/01/01~2019/05/31) |
| Runs (N) | 0 | 3 | 0 | 3 |
| Mean | - | 176.0 | - | 751.3 |
| SD | - | 7.81 | - | 7.77 |
| CV (%) | - | 4.4 | - | 1.0 |
| Target Value | 176 | 176 | 756 | 756 |
| Total Error (%) | - | 8.9 | - | 2.7 |
| TEa (%) | 20 | 20 | 20 | 20 |
| σ | - | 4.5 | - | >6 |
| CI | CII | |||
| QC Control Lot No. | TPC1502AC | TPC1502AD | ||
| ReagentKit | Bio-Rad | |||
| Unit | umol/L blood | |||
| Duration of the Analyzing | Month (2019/05) | CUM (2018/01/01~2019/05/31) | Month (2019/05) | CUM (2018/01/01~2019/05/31) |
| Runs (N) | 1 | 2 | 1 | 2 |
| Mean | 170.0 | 173.5 | 750.0 | 753.0 |
| SD | - | - | - | - |
| CV (%) | - | - | - | - |
| Target Value | 176 | 176 | 756 | 756 |
| Total Error (%) | - | - | - | - |
| TEa (%) | 20 | 20 | 20 | 20 |
| σ | - | - | - | - |
| CI | CII | |||
| QC Control Lot No. | TPC1502AC | TPC1502AD | ||
| ReagentKit | Cambridge | |||
| Unit | umol/L blood | |||
| Duration of the Analyzing | Month (2019/05) | CUM (2018/01/01~2019/05/31) | Month (2019/05) | CUM (2018/01/01~2019/05/31) |
| Runs (N) | 0 | 4 | 0 | 4 |
| Mean | - | 172.0 | - | 761.3 |
| SD | - | 6.48 | - | 14.73 |
| CV (%) | - | 3.8 | - | 1.9 |
| Target Value | 176 | 176 | 756 | 756 |
| Total Error (%) | - | 9.8 | - | 4.6 |
| TEa (%) | 20 | 20 | 20 | 20 |
| σ | - | 4.7 | - | >6 |
|
Bias (%) = [ (│Mean - Target│) / Target ] x 100% TE:Total Error(%) = Bias (%) + 2 × CV (%) σ (Sigma) = [TEa% - Bias (%)] / CV (%) |
| CI and CII SDI QC Chart |
| Lot No.: TPC1502AC ; Reagent : Astoria-Pacific ; Unit: mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 2.9 ; SD : 0.13 ( ●) | ||
| Lot No.: TPC1502AD ; Reagent : Astoria-Pacific ; Unit: mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 12.5 ; SD : 0.67 ( □) |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Bio-Rad ; Unit: mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 2.9 ; SD : 0.13 ( ●) | ||
| Lot No.: TPC1502AD ; Reagent : Bio-Rad ; Unit: mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 12.5 ; SD : 0.67 ( □) |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Cambridge ; Unit: mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 2.9 ; SD : 0.13 ( ●) | ||
| Lot No.: TPC1502AD ; Reagent : Cambridge ; Unit: mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 12.5 ; SD : 0.67 ( □) |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Astoria-Pacific ; Unit: umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 176 ; SD : 9.0 ( ●) | ||
| Lot No.: TPC1502AD ; Reagent : Astoria-Pacific ; Unit: umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 756 ; SD : 40.3 ( □) |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Bio-Rad ; Unit: umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 176 ; SD : 9.0 ( ●) | ||
| Lot No.: TPC1502AD ; Reagent : Bio-Rad ; Unit: umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 756 ; SD : 40.3 ( □) |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Cambridge ; Unit: umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 176 ; SD : 9.0 ( ●) | ||
| Lot No.: TPC1502AD ; Reagent : Cambridge ; Unit: umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 756 ; SD : 40.3 ( □) |
|
|
|
|
||
| CI SDI QC Chart |
| Lot No.: TPC1502AC ; Reagent : Astoria-Pacific ; Unit : mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 2.9 ; SD : 0.13 |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Bio-Rad ; Unit : mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 2.9 ; SD : 0.13 |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Cambridge ; Unit : mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 2.9 ; SD : 0.13 |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Astoria-Pacific ; Unit : umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 176 ; SD : 9.0 |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Bio-Rad ; Unit : umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 176 ; SD : 9.0 |
|
|
|
|
||
| Lot No.: TPC1502AC ; Reagent : Cambridge ; Unit : umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 176 ; SD : 9.0 |
|
|
|
|
||
| CII SDI QC Chart |
| Lot No.: TPC1502AD ; Reagent : Astoria-Pacific ; Unit : mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 12.5 ; SD : 0.67 |
|
|
|
|
||
| Lot No.: TPC1502AD ; Reagent : Bio-Rad ; Unit : mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 12.5 ; SD : 0.67 |
|
|
|
|
||
| Lot No.: TPC1502AD ; Reagent : Cambridge ; Unit : mg/dL blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 12.5 ; SD : 0.67 |
|
|
|
|
||
| Lot No.: TPC1502AD ; Reagent : Astoria-Pacific ; Unit : umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 756 ; SD : 40.3 |
|
|
|
|
||
| Lot No.: TPC1502AD ; Reagent : Bio-Rad ; Unit : umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 756 ; SD : 40.3 |
|
|
|
|
||
| Lot No.: TPC1502AD ; Reagent : Cambridge ; Unit : umol/L blood
Duration : 2018-01-01 to 2019-05-31 ; Target : 756 ; SD : 40.3 |
|
|
|
|
||
Please select a Lab | ||||
| NS001 | NS002 | NS003 | NS004 | NS005 |
| NS006 | NS007 | NS008 | NS009 | NS010 |
| NS011 | NS012 | NS013 | NS014 | NS015 |
| NS016 | NS017 | NS018 | NS019 | NS020 |
| NS021 | NS022 | NS026 | NS030 | NS034 |
| NS035 | NS036 | NS999 | ||
| Home | Application | Peer Group Statistics (Table 1) | Month vs. Cumulative (Table 2) | QC Chart of Individual Lab |
Contact us
Address:
P.O. Box 26-624 Taipei, Taiwan, 10699 Tel:+886-2-703-6080
e-mail:
Fax:
+886-2-2703-6070
Supported by:
Preventive Medicine Foundation, Taipei, Taiwan
updated
: 29 Mar, 2022